Chemical and Pharmaceutical Bulletin p. 777 - 782 (1995)
Update date:2022-08-05
Topics:
Saito
Harada
Nishida
Inouye
Kubo
Treatment of (-)-saframycin A (1a) with selenium oxide in acetic acid afforded (-)-saframycin G (1g), and a catalytic reduction and regioselective oxidation sequence afforded the saframycin Mx type compound (3). We applied this methodology to the transformation of (±)-5-hydroxysaframycin B (11) to the hydroquinone (1e). Acetylation of 1e with acetic anhydride in pyridine gave the triacetate (13), which is identical with the triacetyl derivative of natural saframycin E.
View MoreSynochem Ingredients Corp., Ltd.
Contact:+86-512-5636 2180
Address:Zhangjiagang Free Trade Zone
Contact:0086 533 2282832
Address:Zibo，Shandong
Chengdu ZY Biochemical Technology Co., LTD
Contact:0086-28-88680086
Address:170 Qingpu Road, Shouan Town, Pujiang County
Wuhan Benjamin Pharmaceutical Chemical Co.,Ltd
Contact:86-27-52341789
Address:Room 1518 B suite, optical valley time square, No 111 Guanshan Road, Hongshan District,Wuhan,Hubei Province,China.
Hangzhou Showland Technology Co., Ltd.
Contact:86-571-88920516
Address:ROOM2118,NO.553,WENSAN ROAD,HANGZHOU,CHINA
Doi:10.1016/j.tetasy.2014.04.001
(2014)Doi:10.1021/ol501301w
(2014)Doi:10.1021/acs.jmedchem.7b00592
(2017)Doi:10.1039/c4gc00273c
(2014)Doi:10.1016/j.bmc.2018.05.045
(2018)Doi:10.1016/j.bioorg.2021.104965
(2021)
